Affiliation:
1. Texas Back Institute, 6020 West Parker Road #200, Plano, TX 75093, USA
2. Cornerstone Research Group, 204–3228 South Service Rd., Burlington ON, Canada
Abstract
Aim: To compare the efficacy and safety of total disc replacement, lumbar fusion, and conservative care in the treatment of single-level lumbar degenerative disc disease (DDD). Materials & methods: A network meta-analysis was conducted to determine the relative impact of lumbar DDD therapies on Oswestry Disability Index (ODI) success, back pain score, patient satisfaction, employment status, and reoperation. Odds ratios or mean differences and 95% credible intervals were reported. Results: Six studies were included (1417 participants). Overall, the activL total disc replacement device had the most favorable results for ODI success, back pain, and patient satisfaction. Results for employment status and reoperation were similar across therapies. Conclusion: activL substantially improves ODI success, back pain, and patient satisfaction compared with other therapies for single-level lumbar DDD.
Reference48 articles.
1. Observer variability based on the strength of MR scanners in the assessment of lumbar degenerative disc disease
2. Introduction
3. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
4. North American Spine Society. NASS coverage policy recommendations: lumbar fusion. May 2014 (2014).
5. U.S. Food and Drug Administration (FDA). Summary of safety and effectiveness data, activL artificial disc (2015). www.accessdata.fda.gov/cdrh_docs/pdf12/P120024b.pdf.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献